Related Experiment Video

Updated: Aug 19, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

[Postsurgery meningitis by Staphylococcus aureus: comparison between methicillin-sensitive and resistant strains]

Azucena Rodríguez Guardado1, José Antonio Maradona Hidalgo, Francisco Pérez González

  • 1Unidad de Enfermedades Infecciosas, Hospital Central de Asturias, Oviedo, Spain. cuca22@inicia.es

Medicina Clinica
|February 16, 2005
PubMed
Abstract

Insights

The prognosis for Staphylococcus aureus meningitis after neurosurgery is similar for both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Vancomycin is the recommended treatment for MRSA meningitis.

Area of Science:

  • Infectious Diseases
  • Neurosurgery
  • Microbiology

Context:

  • Postneurosurgical meningitis is a serious complication.
  • Increasing incidence of methicillin-resistant Staphylococcus aureus (MRSA) infections.
  • Need to understand clinical differences between MRSA and MSSA meningitis.

Purpose:

  • Compare clinical characteristics of MRSA vs. MSSA postneurosurgical meningitis.
  • Evaluate and compare the prognosis of MRSA vs. MSSA postneurosurgical meningitis.

Summary:

  • Retrospective review of 25 S. aureus meningitis cases post-neurosurgery.
  • Identified common underlying conditions and risk factors (e.g., hemorrhage, neoplasms, catheters).
  • Outcomes showed no significant difference in prognosis based on methicillin resistance; vancomycin is the treatment of choice for MRSA.

Impact:

  • Informs clinical management of postneurosurgical meningitis.
  • Highlights vancomycin as a key treatment for MRSA meningitis.
  • Contributes to understanding outcomes in neurosurgical infection patients.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...